Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,295 JPY | +0.37% | +3.38% | -8.05% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company appears to be poorly valued given its net asset value.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company does not generate enough profits, which is an alarming weak point.
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.05% | 1.26B | B+ | ||
+5.14% | 103B | A- | ||
-5.63% | 63.04B | A- | ||
+39.52% | 39.06B | B | ||
+12.91% | 37.58B | B | ||
+7.41% | 33.26B | A- | ||
+6.85% | 19.22B | B- | ||
+12.86% | 16.83B | C+ | ||
+7.73% | 15.03B | B | ||
+16.93% | 14.96B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 4061 Stock
- Ratings Denka Company Limited